Product Information

GALANTAMINE HBR 12 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.4960 per EA under NDC 57237005160. Its NADAC has been published 615 times since Apr 9, 2014.

FDA first approved this application on Mar 29, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GALANTAMINE HBR 12 MG TABLET

Galantamine
$0.4960per EA

Strength

12 mg/1

NDC

57237005160

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

GALANTAMINE HYDROBROMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA090957

FDA Approved

3/29/2011

TE Code

AB

On Market Since

3/29/2011

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors

Price Statistics

The NADAC for GALANTAMINE HBR 12 MG TABLET has been published 615 times since Apr 9, 2014, and over the history we have for it it has declined 66.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4960 per EA
All-time high$1.6494 (Nov 11, 2015)
All-time low$0.2712 (Feb 21, 2024)
52-week high$0.5754
52-week low$0.4960
Median price$0.6451
Average price$0.8066
Largest weekly change+126.6% (Jan 19, 2022)
Weeks tracked615
Tracking sinceApr 9, 2014

Price History

1W

-1.6%

1M

-3.3%

3M

-7.0%

6M

-10.1%

1Y

-9.0%

3Y

-3.4%

5Y

+35.1%

All

-66.2%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of GALANTAMINE HBR 12 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for GALANTAMINE HBR 12 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.4960 per EA (NDC 57237005160), effective Nov 18, 2026.

How has the price of GALANTAMINE HBR 12 MG TABLET changed over time?

Over the history we have for it, the NADAC for GALANTAMINE HBR 12 MG TABLET has declined 66.2%. It has been tracked across 615 weekly CMS publications since Apr 9, 2014.

What are the highest and lowest recorded NADAC prices for GALANTAMINE HBR 12 MG TABLET?

Since Apr 9, 2014, the NADAC for GALANTAMINE HBR 12 MG TABLET has ranged from a low of $0.2712 (Feb 21, 2024) to a high of $1.6494 (Nov 11, 2015), with a median of $0.6451 per EA.

Are there cheaper alternatives to GALANTAMINE HBR 12 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as GALANTAMINE HBR 12 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures GALANTAMINE HBR 12 MG TABLET?

GALANTAMINE HBR 12 MG TABLET (NDC 57237005160) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.